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in Malaysia. METHODS: A non-parametric method called Data Envelopment Analy-
sis (DEA) with two assumptions : Variable Return to Scale (VRS) and Constant Return 
to Scale (CRS), was used to calculate and compare the efﬁ ciency scores for selected 
hospitals’ clinical departments between the year 1998 and 2006. DEA input oriented 
analysis indicates how the inefﬁ cient units could adjust their inputs to reach the efﬁ -
ciency frontier. RESULTS: Based on CRS model the mean efﬁ ciency scores in Hospital 
A departments were 76%. One department was around 50% and six departments 
were between 50% and 90% and three departments were more than 90%. The mean 
efﬁ ciency scores in Hospital B was 92%. In this hospital, two departments were 
between 75% and 90% and two departments had efﬁ ciency score equal 100% during 
study period. In Hospital C all departments were more than 75% and one department 
had efﬁ ciency score equals 100%. The results based on VRS model showed similar 
trends. CONCLUSIONS: The mean of efﬁ ciency score according different assump-
tions of Hospital B was higher than two other hospitals. The results showed that few 
departments are efﬁ cient and rests are considered inefﬁ cient and need to ﬁ nd optimum 
mixture of inputs combination. It is suggested that Hospital A and Hospital C should 
consider to improve their management of the resource inputs in inefﬁ cient department 
in order to enhance their efﬁ ciencies. 
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OBJECTIVES: A growing concern is that health policy and system researches (HPSR) 
should address the needs of potential users, and subsequently have substantial impacts 
on policy decisions and professional practices. The purpose of this study is to describe 
the experience on the annual HPSR topic prioritization conducted by Thailand’s 
Health Systems Research Institute and its alliances. METHODS: Narrative descriptive 
and quantitative approaches were employed to illustrate the processes of and results 
from the HPSR topic prioritization in 2010. RESULTS: The prioritization process was 
carried out on the basis of systematicness and transparency, with participation by key 
stakeholders including policymakers, academics, health professionals, civil society, 
and industries. There was a call for research topic proposals from stakeholders in 
November and December 2009. A total of 120 topics suggested by 66 organizations 
were then prioritized by 90 representatives of stakeholder organizations. Multiple 
criteria introduced in this step involved policy relevance; disease burden; economic 
impact; social and ethical aspects; variation in practices; possibility of changing prac-
tices; and public concerns. It was found that topics related to diseases with high 
burden, relating to service delivery especially on health promotion and disease preven-
tion, and those submitted by central government agencies were more likely to get high 
priority than others. In addition, results from self-administrative survey demonstrated 
that over 92% of stakeholders strongly supported and expressed their interest to 
participate in the next annual topic prioritization process. CONCLUSIONS: This case 
study demonstrated that it is feasible to develop clear criteria and transparent process 
for prioritization of HPSR topics. Lessons learned from this case study can be useful 
for improving mechanism for selecting HPSR topics in other settings. 
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OBJECTIVES: In Australia, the Pharmaceutical Beneﬁ ts Advisory Committee (PBAC) 
makes recommendations to the Minister for Health on the reimbursement of pharma-
ceuticals. The sponsor’s submission is accepted by the PBAC if the drug is determined 
to be clinically effective and also cost-effective. New PBAC Guidelines on how to 
prepare a submission (version 4) were introduced in 2008. These new Guidelines 
sought to reduce the uncertainty for the PBAC in accepting the many inferences made 
in major submissions. We assessed whether the New Guidelines have indeed reduced 
the PBAC’s uncertainty in their decision-making. METHODS: Since June 2003 all 
PBAC recommendations have been made public on the Department of Health & 
Ageing website. Public Summary Documents (PSD) are available for PBAC consider-
ations relating to the PBS listing of medicines since July 2005 meeting. We reviewed 
all the PSDs reported during the period of July 2005 to July 2009. For each PSD, we 
estimated the average number of times that the words “uncertain/uncertainties/uncer-
tainty” appear per PSD page. We compared the results for the period before and after 
the introduction of version 4 of the PBAC Guidelines. RESULTS: The average number 
of times that the words “uncertain/uncertainties/uncertainty” appeared per PSD page 
was signiﬁ cantly higher for the period after the introduction of version 4 of the PBAC 
Guidelines compared to the period before (0.51 vs. 0.66, P < 0.00001). CONCLU-
SIONS: The introduction of version 4 of the PBAC Guidelines in 2008 has led to an 
increase in the complexity and, thus, uncertainty faced by PBAC during their delibera-
tions around reimbursement of pharmaceuticals in Australia. There was a signiﬁ cant 
30% increase in the number of times that the word “uncertain/uncertainties/uncer-
tainty” was found per PSD page compared with the period prior to the introduction 
of the version 4 of the Guidelines (2003–2008). 
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OBJECTIVES: In 2006, the reimbursement system for civil-servant medical beneﬁ t 
schemes beneﬁ ciaries in Thailand was changed to direct billing system. It was 
unknown how this new system affects drug expenditures and the number of drug 
supply given to beneﬁ ciaries. This study aims to assess the effects of direct billing 
system on prescribing patterns. METHODS: This study was undertaken with retro-
spective cohort approach. We used the data recorded in databases of a university 
hospital in northern part of Thailand. We undertook the data on all patients with 
civil-servant medical beneﬁ t schemes who came to out-patients department between 
October 1, 2005 and March 31, 2007. Mean cost of medication, number of days’ 
supplies and medication possession ratio (MPR) of ﬁ ve highest costs of oral medication 
were calculated in 1 year before and after the system was changed. RESULTS: Out 
of 43,897 visits made at the hospital, 15,632 (36%) were under civil-servant medical 
beneﬁ t schemes. Eighty-eight percent (13,785/15,632) received medications during 
visit. The total costs of medication increased from 2 million to 4 million baths in 1 
year. Glucosamine, atorvastatin, rosiglitazone, clopidogrel and diacerin were highest 
used in terms of drug cost. Averages of day’s supplies based on these medications 
increased from 1.29 to 1.48 months per a prescription. Proportion of patients receiving 
medications more than 3 months, was slightly increased from 1.82% to 2.43%. Three 
out of ﬁ ve medications had higher MPR after system was changed (Relative risk 
ranged on 1.19–2.32). Two of these were statistical signiﬁ cant. CONCLUSIONS: The 
direct billing system affects prescribing patterns as indicated by trend of increased 
number of day’s supplies and higher medication possession ratio. Further evidence 
remains needed. Policymakers need to consider all relevant and important conse-
quences associated with the new system prior to making policy decision-making. 
INDIVIDUAL’S HEALTH – Clinical Outcomes Studies
PIH1
CRITICAL APPRAISAL OF SYSTEMATIC REVIEWS ASSESSING SAFETY 
OUTCOMES OF SSRIS IN THE PERINATAL PERIOD
Merlo GB, Elliot L, Campbell S, Norris S
Health Technology Analysts Pty Ltd, Sydney, NSW, Australia
OBJECTIVES: A systematic appraisal was conducted of published systematic reviews 
that assessed the harms associated with selective serotonergic reuptake inhibitors 
(SSRIs) in the perinatal period, both for the mother and infant. METHODS: A sys-
tematic method of literature searching and selection was employed for this review. 
Searches were conducted in EMBASE, Medline and the Cochrane Database of Sys-
tematic Reviews. Studies were eligible if they evaluated pregnancy or infant-related 
safety outcomes for SSRI use in pregnant or lactating women. RESULTS: The litera-
ture search identiﬁ ed seventeen systematic reviews and three subsequently published 
prospective cohort studies. None of the systematic reviews assessing serotonergic 
antidepressants as a group found an association with congenital malformations. An 
association between paroxetine exposure and infant cardiovascular malformations has 
been reported in the literature; however, more recent evidence from a large systematic 
review shows no relationship between paroxetine exposure and congenital cardiac 
malformations. Neonatal symptoms (such as withdrawal symptoms, lower Apgar 
score, and diminished response to pain stimulus) have been reported in 20–30% of 
infants with third trimester SSRI exposure. All of the reviews reported the symptoms 
as mild and self-limiting. Several SRs found a signiﬁ cant association between SSRI use 
in pregnancy and premature delivery, low birthweight, and admission to special care 
nurseries. There is conﬂ icting evidence regarding the long-term neurodevelopmental 
risks of serotonergic antidepressants. Although the levels of SSRIs in breast milk are 
relatively low, the evidence for the safety of antidepressant exposure via breastfeeding 
is limited. CONCLUSIONS: SSRI exposure during pregnancy is associated with 
mostly minor and temporary adverse outcomes for the newborn. The risk of these 
outcomes needs to be balanced with the risk of adverse outcomes resulting from SSRI 
withdrawal for the mother. 
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OBJECTIVES: Estimate the potential clinical effect of HPV vaccination with a bivalent 
HPV-16/18 vaccine in Asian countries including the effect of cross-protection against 
non-vaccine oncogenic HPV types. METHODS: A static population model estimates 
